(CVS) CVS Caremark Analyst Maintains Neutral on Shares
Recently, we reiterated our Neutral recommendation on CVS Caremark Corporation (CVS) with a target price of $41.00. CVS Caremark reported an adjusted EPS of 57 cents in the first quarter of 2011, beating the Zacks Consensus Estimate of 55 cents but trailing the year-ago quarter’s adjusted EPS of 60 cents. After sluggish performance in past [...] (CVS) CVS Caremark Analyst Maintains Neutral on Shares
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here